BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 38474093)

  • 1. Bridging the Gap in Understanding Bone Metastasis: A Multifaceted Perspective.
    Elaasser B; Arakil N; Mohammad KS
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondins in bone remodeling and metastatic bone disease.
    Carminati L; Taraboletti G
    Am J Physiol Cell Physiol; 2020 Dec; 319(6):C980-C990. PubMed ID: 32936697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer metastasis to the bone: mechanisms of bone loss.
    Chen YC; Sosnoski DM; Mastro AM
    Breast Cancer Res; 2010; 12(6):215. PubMed ID: 21176175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Metastasis of Breast Cancer.
    Tahara RK; Brewer TM; Theriault RL; Ueno NT
    Adv Exp Med Biol; 2019; 1152():105-129. PubMed ID: 31456182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic modeling of bone metastasis, microenvironment and therapy: Integrating parathyroid hormone (PTH) effect, anti-resorptive and anti-cancer therapy.
    Coelho RM; Lemos JM; Alho I; Valério D; Ferreira AR; Costa L; Vinga S
    J Theor Biol; 2016 Feb; 391():1-12. PubMed ID: 26657065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases.
    Hiraga T
    Expert Opin Investig Drugs; 2016; 25(3):319-34. PubMed ID: 26778342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases.
    Whang YM; Jung SP; Kim MK; Chang IH; Park SI
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted microRNAs in bone metastasis.
    Taipaleenmäki H
    J Bone Miner Metab; 2023 May; 41(3):358-364. PubMed ID: 37031329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
    Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth.
    Kreps LM; Addison CL
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis.
    Lynch CC
    Bone; 2011 Jan; 48(1):44-53. PubMed ID: 20601294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer.
    Araujo A; Cook LM; Lynch CC; Basanta D
    Cancer Res; 2014 May; 74(9):2391-401. PubMed ID: 24788098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.
    Sterling JA; Edwards JR; Martin TJ; Mundy GR
    Bone; 2011 Jan; 48(1):6-15. PubMed ID: 20643235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions.
    Loberg RD; Gayed BA; Olson KB; Pienta KJ
    J Cell Biochem; 2005 Oct; 96(3):439-46. PubMed ID: 15988761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of bone metastasis in solid tumors: a review.
    Vičić I; Belev B
    Croat Med J; 2021 Jun; 62(3):270-282. PubMed ID: 34212564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging therapies in bone metastasis.
    Clément-Demange L; Clézardin P
    Curr Opin Pharmacol; 2015 Jun; 22():79-86. PubMed ID: 25935860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease.
    Turner CJ; Edwards CM
    Curr Osteoporos Rep; 2016 Oct; 14(5):170-7. PubMed ID: 27566487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone-targeting agents in prostate cancer.
    Suzman DL; Boikos SA; Carducci MA
    Cancer Metastasis Rev; 2014 Sep; 33(2-3):619-28. PubMed ID: 24398856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
    Futakuchi M; Fukamachi K; Suzui M
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical role of the bone microenvironment in cancer metastases.
    Casimiro S; Guise TA; Chirgwin J
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):71-81. PubMed ID: 19616059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.